Case of acquired haemophilia a in Southeast Asia following COVID-19 vaccine

Acquired haemophilia A (AHA) is a rare bleeding disorder with high morbidity and mortality, but it is eminently treatable if diagnosis and treatment are prompt. We report a case of AHA in Southeast Asia following the administration of the Pfizer-BioNTech COVID-19 vaccine. A man in his 80s developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai Vuen, Lee, Aun Su-Yin, Evelyn, Naila Kori, Ahlam, Shah, TM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Reports: Unusual association of diseases/symptoms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915366/
https://www.ncbi.nlm.nih.gov/pubmed/35264381
http://dx.doi.org/10.1136/bcr-2021-246922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915366/
https://www.ncbi.nlm.nih.gov/pubmed/35264381
http://dx.doi.org/10.1136/bcr-2021-246922

Ejemplares similares